Are you Dr. Wernicke?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 6 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
447 W 91st St
Indianapolis, IN 46260Phone+1 319-440-2353
Education & Training
David Geffen School of Medicine at UCLAClass of 1979
Certifications & Licensure
CA State Medical License 1980 - Present
IN State Medical License 1999 - 2025
TX State Medical License 1990 - 2024
Publications & Presentations
PubMed
- 32 citationsHepatic effects of duloxetine-I: non-clinical and clinical trial data.Joachim F. Wernicke, Beth A. Pangallo, Fujun Wang, Isabelle Murray, Judith W. Henck
Current Drug Safety. 2008-05-01 - 23 citationsHepatic effects of duloxetine-II: spontaneous reports and epidemiology of hepatic eventsJoachim F. Wernicke, Nayan Acharya, James Gahimer, Deborah N. D'Souza, Natalie DiPietro
Current Drug Safety. 2008-05-01 - 133 citationsCardiovascular effects of Atomoxetine in children, adolescents, and adultsJoachim F. Wernicke, Douglas E. Faries, Donald A. Girod, Jeffrey W. Brown, Haitao Gao
Drug Safety. 2003-01-01
